Grieco, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 9.992
EU - Europa 8.453
AS - Asia 7.854
SA - Sud America 1.558
AF - Africa 183
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 27
Totale 28.104
Nazione #
US - Stati Uniti d'America 9.775
SG - Singapore 3.626
DE - Germania 3.205
CN - Cina 1.896
SE - Svezia 1.372
BR - Brasile 1.295
IT - Italia 841
VN - Vietnam 726
UA - Ucraina 710
FR - Francia 598
GB - Regno Unito 396
IE - Irlanda 387
FI - Finlandia 276
ID - Indonesia 264
IN - India 264
RU - Federazione Russa 216
JP - Giappone 204
TR - Turchia 202
HK - Hong Kong 153
AR - Argentina 113
BD - Bangladesh 113
PL - Polonia 112
CA - Canada 105
IQ - Iraq 84
MX - Messico 53
AT - Austria 52
NL - Olanda 52
ZA - Sudafrica 48
BE - Belgio 43
ES - Italia 43
KR - Corea 35
EC - Ecuador 34
PK - Pakistan 31
SA - Arabia Saudita 30
AU - Australia 29
IR - Iran 29
MA - Marocco 26
VE - Venezuela 25
CO - Colombia 24
UZ - Uzbekistan 24
AE - Emirati Arabi Uniti 22
EU - Europa 22
PH - Filippine 22
JO - Giordania 20
KE - Kenya 20
RO - Romania 20
CL - Cile 17
EG - Egitto 17
PE - Perù 16
PT - Portogallo 16
CH - Svizzera 15
DZ - Algeria 15
PY - Paraguay 15
CZ - Repubblica Ceca 14
CI - Costa d'Avorio 13
LT - Lituania 13
PA - Panama 13
IL - Israele 12
MY - Malesia 11
TN - Tunisia 11
AZ - Azerbaigian 10
TT - Trinidad e Tobago 10
AL - Albania 9
BO - Bolivia 9
DK - Danimarca 9
HU - Ungheria 8
JM - Giamaica 8
KG - Kirghizistan 7
NG - Nigeria 7
NP - Nepal 7
OM - Oman 7
TH - Thailandia 7
UY - Uruguay 7
CR - Costa Rica 6
LK - Sri Lanka 6
NZ - Nuova Zelanda 6
BG - Bulgaria 5
BZ - Belize 5
ET - Etiopia 5
GR - Grecia 5
KW - Kuwait 5
KZ - Kazakistan 5
LB - Libano 5
MK - Macedonia 5
DO - Repubblica Dominicana 4
EE - Estonia 4
GE - Georgia 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
BY - Bielorussia 3
CY - Cipro 3
IS - Islanda 3
KH - Cambogia 3
MD - Moldavia 3
NI - Nicaragua 3
NO - Norvegia 3
RE - Reunion 3
RS - Serbia 3
SC - Seychelles 3
Totale 28.050
Città #
Singapore 1.903
Chandler 1.359
Ashburn 1.028
San Jose 1.007
Jacksonville 407
Dublin 385
Beijing 360
San Mateo 334
New York 259
Ho Chi Minh City 257
Frankfurt am Main 250
Nanjing 238
Jakarta 237
Ann Arbor 222
Lauterbourg 208
Los Angeles 208
Dallas 194
Wilmington 194
Boston 189
Tokyo 184
Nürnberg 179
Hefei 166
Houston 161
Munich 158
Hanoi 157
Izmir 152
Cattolica 151
Milan 146
Dearborn 139
Rome 134
Hong Kong 130
Princeton 125
São Paulo 122
Woodbridge 119
Moscow 117
The Dalles 108
Marseille 101
Nanchang 98
Chicago 94
Helsinki 94
Seattle 77
Boardman 75
Buffalo 75
Redwood City 68
Santa Clara 66
Lawrence 65
Redmond 63
Fairfield 57
Tianjin 57
Hebei 55
Kraków 55
Council Bluffs 53
London 49
Mountain View 46
Paris 46
Bremen 45
Shenyang 44
Rio de Janeiro 43
Brussels 42
Kunming 42
Brooklyn 41
University Park 39
Da Nang 38
Kent 38
Zhengzhou 38
Guangzhou 37
Jiaxing 37
Orem 37
Warsaw 37
Hangzhou 36
Norwalk 36
Changsha 35
Baghdad 34
Nuremberg 34
Augusta 32
Seoul 32
Turku 32
Haiphong 31
Belo Horizonte 30
Phoenix 30
Fremont 28
Toronto 28
Denver 27
Dhaka 27
Düsseldorf 27
Jinan 27
Montreal 27
San Francisco 27
Washington 27
Poplar 26
Atlanta 25
St Louis 25
Amsterdam 24
Pune 24
Shanghai 23
Stockholm 23
Bexley 22
Cambridge 22
Johannesburg 22
Tashkent 22
Totale 14.404
Nome #
Gastrointestinal amyloidosis: a case of chronic diarrhoea. 348
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 323
A phase II study of sunitinib in advanced hepatocellular carcinoma 269
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 264
13C-methionine breath tests for mitochondrial liver function assessment. 260
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? 257
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 242
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 236
-Hepatic steatosis and vascular disease 235
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 228
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 227
134C-breath tests in the study of mitochondrial liver function 217
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 214
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 207
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 203
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 200
13C-breath tests in the study of microsomial liver function 200
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 199
13C-methionine breath tests for mitochondrial liver function assessment 192
Effect of sildenafil on diabetic gastropathy. 189
Epicardial fat thickness correlates with body fat stores, insulin resistance and alanine aminotransferase in patients affected by nonalcoholic steatohepatitis (NASH) 188
Liver transplantation in patients with alcoholic liver disease: A retrospective study 186
recurrent acute hepatitis associated with use of cetrizine 183
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 181
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 178
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 178
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 177
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 176
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 174
Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver 174
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 174
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 173
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 173
Potential use of liver function breath tests in the clinical practice. 172
Vanishing-recurrent benign liver lesions 172
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 171
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 170
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 167
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 166
13C-breath tests in the study of mitochondrial liver function 165
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 165
Cryoglobulinemia: a true internistic disease? 163
-Fatty liver and drugs 160
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 160
[The treatment of hepatocellular carcinoma: an update] 160
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 159
Erythrocyte viscoelastic recovery after liver transplantation in a cirrhotic patient affected by spur cell anaemia 157
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 156
Faecal calprotectin concentrations in untreated coeliac patients 155
gastroesophageal reflux disease: facts and uncertaines 153
Bone metastasis in hepatocellular carcinoma. A report of five cases and a review of the literature. 152
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 152
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 151
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 148
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 147
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 147
Severe giant cell arteritis associated with essential thrombocythaemia. 146
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 146
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 146
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 146
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 146
Tromboembolism and breast cancer: the hidden risk for patient and physician 144
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease 144
Liver resection for hepatocellular carcinoma in patient with situs inversus viscerum 144
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 142
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 141
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 141
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 141
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic Fatty liver disease 140
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 140
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 139
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial 138
-Nonalcoholic fatty liver disease: defining a common problem 138
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 137
FAECAL CALPROTECTIN CONCENTRATIONS IN UNTREATED CELIAC PATIENTS 136
Advanced colon cancer: staging and prognosis by CEA test 136
Antipyrine clearance in chronic and neoplastic liver diseases: a study of 518 patients. 135
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 135
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 134
Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms. 134
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 134
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 133
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 133
Braised liver with herbs: the risks of naturopathic hepatoprotection. 132
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 132
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 132
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 131
Alcoholic and nonalcoholic forms of fatty liver disease. 128
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. 126
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. 125
The role of elastography in non-Alcoholic fatty liver disease 125
Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the Treatment of Advanced HCC with Arterioportal Shunt 124
Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia 124
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 123
Gender affects 13C-ketoisocaproic acid breath test 122
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 122
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 122
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 122
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 120
A giant calcified hepatic mass 120
Totale 16.592
Categoria #
all - tutte 114.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021306 0 0 0 0 0 0 0 0 0 0 274 32
2021/20221.752 67 162 46 177 123 43 29 287 60 89 320 349
2022/20233.728 492 488 290 539 283 448 163 340 429 51 151 54
2023/20241.875 119 558 77 88 80 272 119 64 23 76 162 237
2024/20253.873 99 107 334 121 304 146 87 211 606 402 773 683
2025/20269.677 1.530 306 672 1.107 1.722 634 1.799 490 701 706 10 0
Totale 28.410